Crinetics Pharma Shares Hit 52-Week High After Oversubscribed Private Placement

By Chris Wack Crinetics Pharmaceuticals shares were up 15% at $46.60 after the company agreed to sell 8.3 million shares at a price of $42 a share to a...

Related Keywords

Chris Wack ,Crinetics Pharmaceuticals ,Adage Capital Partners ,Driehaus Capital Management ,First Light Asset ,Article Normal ,Pharmaceuticals ,Trusts Funds Financial Vehicles ,Financial Investment Services ,Portfolio Fund Asset Management ,Healthcare Life Sciences ,Alternative Investments ,Financial Services ,Hedge Funds ,Investing Securities ,Corporate Funding ,Ownership Changes ,Acquisitions Mergers Shareholdings ,Corporate Actions ,Corporate Industrial News ,Private Placements ,Content Types ,Factiva Filters ,C Amp Ampe Industry News Filter ,Synd ,Crnx ,Acquisitions ,Mergers ,Shareholdings ,Corporate ,Industrial News ,Trusts ,Funds ,Financial Vehicles ,Portfolio ,Fund ,Asset Management ,Healthcare ,Life Sciences ,Investing ,Securities ,